A detailed history of Stephens Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stephens Inc holds 575,581 shares of MRK stock, worth $56.1 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
575,581
Previous 553,923 3.91%
Holding current value
$56.1 Million
Previous $68.6 Million 4.69%
% of portfolio
0.97%
Previous 1.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$111.15 - $128.97 $2.41 Million - $2.79 Million
21,658 Added 3.91%
575,581 $65.4 Million
Q2 2024

Aug 06, 2024

BUY
$123.8 - $132.96 $925,157 - $993,610
7,473 Added 1.37%
553,923 $68.6 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $1.52 Million - $1.78 Million
13,465 Added 2.53%
546,450 $72.1 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $3.06 Million - $3.33 Million
30,527 Added 6.08%
532,985 $58.1 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $535,237 - $594,401
-5,199 Reduced 1.02%
502,458 $51.7 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $1.59 Million - $1.73 Million
14,623 Added 2.97%
507,657 $58.6 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $1.8 Million - $2.01 Million
-17,481 Reduced 3.42%
493,034 $52.5 Million
Q4 2022

Jan 25, 2023

BUY
$87.44 - $112.11 $1.26 Million - $1.62 Million
14,425 Added 2.91%
510,515 $56.6 Million
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $7.76 Million - $8.72 Million
91,849 Added 22.72%
496,090 $42.7 Million
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $1.27 Million - $1.44 Million
15,179 Added 3.9%
404,241 $36.9 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $2.18 Million - $2.45 Million
29,707 Added 8.27%
389,062 $31.9 Million
Q4 2021

Mar 07, 2022

SELL
$72.28 - $90.54 $7.04 Million - $8.82 Million
-97,394 Reduced 21.32%
359,355 $27.5 Million
Q3 2021

Oct 27, 2021

BUY
$71.68 - $78.83 $1.04 Million - $1.15 Million
14,542 Added 3.29%
456,749 $34.3 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $3.52 Million - $3.9 Million
50,114 Added 12.78%
442,207 $34.4 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $2.37 Million - $2.79 Million
34,380 Added 9.61%
392,093 $30.2 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $1.17 Million - $1.3 Million
-16,312 Reduced 4.36%
357,713 $29.3 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $70,691 - $80,129
-966 Reduced 0.26%
374,025 $31 Million
Q2 2020

Aug 24, 2020

BUY
$70.42 - $80.13 $3.8 Million - $4.33 Million
53,976 Added 16.81%
374,991 $29 Million
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $3.73 Million - $5.17 Million
58,831 Added 22.44%
321,015 $24.7 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $177,658 - $200,466
-2,290 Reduced 0.87%
262,184 $23.8 Million
Q3 2019

Oct 18, 2019

SELL
$76.08 - $82.93 $1.19 Million - $1.29 Million
-15,604 Reduced 5.57%
264,474 $22.3 Million
Q2 2019

Aug 01, 2019

BUY
$69.84 - $81.59 $142,613 - $166,606
2,042 Added 0.73%
280,078 $23.5 Million
Q1 2019

May 03, 2019

BUY
$69.58 - $79.36 $290,913 - $331,804
4,181 Added 1.53%
278,036 $23.1 Million
Q4 2018

Feb 11, 2019

BUY
$65.24 - $75.71 $182,476 - $211,760
2,797 Added 1.03%
273,855 $20.9 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $339,447 - $399,170
5,884 Added 2.22%
271,058 $19.2 Million
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $5.1 Million - $5.99 Million
-100,322 Reduced 27.45%
265,174 $16.1 Million
Q1 2018

May 03, 2018

BUY
$50.96 - $59.23 $485,444 - $564,224
9,526 Added 2.68%
365,496 $19.9 Million
Q4 2017

Feb 05, 2018

SELL
$51.62 - $61.64 $92,709 - $110,705
-1,796 Reduced 0.5%
355,970 $20 Million
Q3 2017

Nov 08, 2017

SELL
$58.67 - $63.13 $632,345 - $680,415
-10,778 Reduced 2.92%
357,766 $22.9 Million
Q2 2017

Aug 10, 2017

BUY
N/A
368,544
368,544 $23.6 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.